Category Archives: AUSTRALIAN HEALTH CARE STOCK

Healthscope Ltd Sale of standalone medical centres operations

Sale of standalone medical centres operations: Healthscope Ltd (ASX: HSO) has entered into an agreement to sell its standalone medical centres operations for A$55 million to Fullerton Primary Care Pty Ltd (subsidiary of Fullerton Australia). The transaction is expected to be complete by the end of September 2017. Healthscope’s standalone medical centres operations consist of 43 medical centres, four specialist

Read more

What is the latest with these 2 healthcare stocks – Healthscope and Primary Health Care

Sale of standalone medical centres operations: Healthscope Ltd (ASX: HSO) has entered into an agreement to sell its standalone medical centres operations for A$55 million to Fullerton Primary Care Pty Ltd (subsidiary of Fullerton Australia). The transaction is expected to be complete by the end of September 2017. Healthscope’s standalone medical centres operations consist of 43 medical centres, four specialist

Read more

Why we think Somnomed Limited shares can soar higher?

Strong Q4 growth across geographies: SomnoMed Limited (ASX: SOM) reported strong sales in the US during the quarter (+24% over prior year), combined with ongoing strong Q4 growth in Europe (+20.6%), resulted in record total group unit quarterly sales of 19,859 units (+24.2%). Total device sales for the FY17 stood at 68,100 units. Unaudited quarterly group revenues grew by 22%

Read more

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation.

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation. During H1FY17, JHC had reported a revenue growth of 14.5% year on year (yoy) to $178.5 million while EBITDA grew by 3.6% yoy to $29.1 million. However, it has witnessed a decline of 9.9% yoy in net profit

Read more

2 ways you can profit from Australia’s ageing population – Japara Healthcare and Ramsay Health care

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation. During H1FY17, JHC had reported a revenue growth of 14.5% year on year (yoy) to $178.5 million while EBITDA grew by 3.6% yoy to $29.1 million. However, it has witnessed a decline of 9.9% yoy in net profit

Read more
« Older Entries